Soldatov N
ISRN Biochem. 2015; 2013:463527.
PMID: 25937960
PMC: 4392978.
DOI: 10.1155/2013/463527.
Matsukado K, Ikezaki K, Nomura T, Fukui M
J Neurooncol. 1996; 27(1):1-10.
PMID: 8699220
DOI: 10.1007/BF00146078.
Watson W, Little H
Psychopharmacology (Berl). 1994; 114(2):329-36.
PMID: 7838926
DOI: 10.1007/BF02244856.
Guard S, Boyle S, Tang K, Watling K, McKnight A, Woodruff G
Br J Pharmacol. 1993; 110(1):385-91.
PMID: 7693284
PMC: 2176003.
DOI: 10.1111/j.1476-5381.1993.tb13821.x.
Spedding M
Br J Pharmacol. 1983; 80(3):485-8.
PMID: 6640202
PMC: 2044998.
DOI: 10.1111/j.1476-5381.1983.tb10719.x.
A unitary mechanism of calcium antagonist drug action.
Murphy K, Gould R, Largent B, Snyder S
Proc Natl Acad Sci U S A. 1983; 80(3):860-4.
PMID: 6572372
PMC: 393480.
DOI: 10.1073/pnas.80.3.860.
Voltage-sensitive calcium flux promoted by vesicles in an isolated cardiac sarcolemma preparation.
Schilling W, Lindenmayer G
J Membr Biol. 1984; 79(2):163-73.
PMID: 6431112
DOI: 10.1007/BF01872120.
Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow M, Ginsburg R, Laser J, McAuley B, Minobe W
Br J Pharmacol. 1984; 82(2):309-20.
PMID: 6329392
PMC: 1987032.
DOI: 10.1111/j.1476-5381.1984.tb10765.x.
Interaction of calcium channel blockers with non-neuronal benzodiazepine binding sites.
Cantor E, Kenessey A, SEMENUK G, Spector S
Proc Natl Acad Sci U S A. 1984; 81(5):1549-52.
PMID: 6324202
PMC: 344874.
DOI: 10.1073/pnas.81.5.1549.
Calcium channel activation: a different type of drug action.
Freedman S, Miller R
Proc Natl Acad Sci U S A. 1984; 81(17):5580-3.
PMID: 6206501
PMC: 391750.
DOI: 10.1073/pnas.81.17.5580.
Differential effects of nifedipine, verapamil, and diltiazem on noradrenaline-induced contractions, adrenergic transmitter release, and alpha-adrenoceptor binding in the female rabbit urethra.
Larsson B, Hogestatt E, Mattiasson A, Andersson K
Naunyn Schmiedebergs Arch Pharmacol. 1984; 326(1):14-21.
PMID: 6147759
DOI: 10.1007/BF00518773.
Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.
Spedding M, Berg C
Naunyn Schmiedebergs Arch Pharmacol. 1984; 328(1):69-75.
PMID: 6083458
DOI: 10.1007/BF00496109.
High and concentration-proportional accumulation of [3H]-nitrendipine by intact cardiac tissue.
LULLMANN H, Mohr K
Br J Pharmacol. 1987; 90(3):567-74.
PMID: 3567462
PMC: 1917193.
DOI: 10.1111/j.1476-5381.1987.tb11207.x.
[3H]-verapamil binding to rat cardiac sarcolemmal membrane fragments; an effect of ischaemia.
Dillon J, NAYLER W
Br J Pharmacol. 1987; 90(1):99-109.
PMID: 3028561
PMC: 1917274.
DOI: 10.1111/j.1476-5381.1987.tb16829.x.
Phencyclidine increases the affinity of dihydropyridine calcium channel antagonist binding in rat brain.
Bolger G, Rafferty M, Skolnick P
Naunyn Schmiedebergs Arch Pharmacol. 1985; 330(3):227-34.
PMID: 2932650
DOI: 10.1007/BF00572438.
Calcium channels: molecular pharmacology, structure and regulation.
Hosey M, Lazdunski M
J Membr Biol. 1988; 104(2):81-105.
PMID: 2903935
DOI: 10.1007/BF01870922.
Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells.
Uehara A, Hume J
J Gen Physiol. 1985; 85(5):621-47.
PMID: 2582076
PMC: 2215823.
DOI: 10.1085/jgp.85.5.621.
Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain.
Morel N, GODFRAIND T
Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(4):442-51.
PMID: 2555723
DOI: 10.1007/BF00167047.
Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
Imagawa J, Satoh K, Taira N
Cardiovasc Drugs Ther. 1989; 3(1):81-90.
PMID: 2487526
DOI: 10.1007/BF01881532.
The molecular pharmacology and structural features of calcium channels.
Ferry D, Goll A, Rombusch M, Glossmann H
Br J Clin Pharmacol. 1985; 20 Suppl 2:233S-246S.
PMID: 2413875
PMC: 1400655.
DOI: 10.1111/j.1365-2125.1985.tb02809.x.
